drugset / Trial / NCT03589495

Safety and Efficacy of Adding Intravenous N-acetyl Cysteine in Colon Surgeries

NCT03589495

Phase 4 Completed 60 enrolled Ain Shams University
RandomizedParallel-groupDouble-blindPrevention

Summary

The use of antioxidant agents in the prevention or decreasing the severity of postoperative systemic inflammatory response syndrome after colonic surgeries adopted nowadays. Therefore, it is of interest to investigate safety and efficacy of administrating short term intravenous (IV) N acetyl cysteine as add on to l alany l glutamine and total parenteral nutrition on the marker of oxidative stress malondialdehyde and anti- inflammatory marker tumor necrosis factor alpha in patients undergoing colonic surgeries through a prospective, randomized, double blinded, controlled clinical trial

Timeline

Start
2015-07-30
Primary completion
2016-10-15
Completion
2016-10-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator N-acetylcysteine Small molecule 50 mg/kg Intravenous

Indications

No indication recorded.